Exam 4 - HIV Stahelin (ChatGPT made these) Flashcards

1
Q

What is meant by the genetic barrier to resistance in the context of HIV treatment?

A) The ability of the virus to mutate and become resistant to a single drug
B) The number of mutations required for the virus to become resistant to a drug
C) The effectiveness of a drug in preventing viral replication
D) The ability of the immune system to recognize and destroy the virus

A

B) The number of mutations required for the virus to become resistant to a drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which step in the HIV life cycle is targeted by nucleoside reverse transcriptase inhibitors (NRTIs)?

A) Viral entry into host cells
B) Integration of viral DNA into the host genome
C) Reverse transcription of viral RNA into DNA
D) Assembly and maturation of new virions

A

C) Reverse transcription of viral RNA into DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How are nucleoside reverse transcriptase inhibitors (NRTIs) activated metabolically before they can inhibit the enzyme?

A) They are phosphorylated to their triphosphate form by cellular kinases
B) They are cleaved by viral proteases
C) They are methylated by host enzymes
D) They are acetylated by viral enzymes

A

A) They are phosphorylated to their triphosphate form by cellular kinases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which structural feature differentiates nucleoside analogues from normal nucleosides used by reverse transcriptase?

A) Lack of a 3’ hydroxyl group
B) Presence of a 5’ phosphate group
C) Addition of a methyl group at the 2’ position
D) Presence of a double bond in the sugar ring

A

A) Lack of a 3’ hydroxyl group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the role of the HLA-B*5701 polymorphism in the hypersensitivity reaction caused by abacavir?

A) It increases the drug’s efficacy
B) It reduces the drug’s side effects
C) It is associated with a higher risk of hypersensitivity reaction
D) It enhances the drug’s absorption

A

C) It is associated with a higher risk of hypersensitivity reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which NRTI is known for having a longer half-life due to its unique activation pathway?

A) Abacavir
B) Emtricitabine
C) Tenofovir alafenamide
D) Lamivudine

A

C) Tenofovir alafenamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which class of drugs inhibits the integration of HIV DNA into the host genome?

A) NRTIs
B) NNRTIs
C) Integrase inhibitors
D) Protease inhibitors

A

C) Integrase inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which NNRTI is associated with severe hepatotoxicity and rash, including Stevens-Johnson syndrome?

A) Nevirapine
B) Efavirenz
C) Delavirdine
D) Etravirine

A

A) Nevirapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do non-nucleoside reverse transcriptase inhibitors (NNRTIs) inhibit reverse transcriptase?

A) By competing with nucleotides for binding
B) By binding to a hydrophobic pocket near the catalytic site
C) By phosphorylating the enzyme
D) By cleaving the enzyme

A

B) By binding to a hydrophobic pocket near the catalytic site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which structural feature allows HIV integrase inhibitors to inhibit the enzyme?

A) Chelation of divalent metal ions
B) Binding to the active site of reverse transcriptase
C) Inhibition of viral entry
D) Blocking the protease cleavage site

A

A) Chelation of divalent metal ions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which protease inhibitor is known for making extensive hydrogen bonds with the protease backbone, reducing the impact of resistance mutations?

A) Atazanavir
B) Darunavir
C) Tipranavir
D) Ritonavir

A

B) Darunavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the mechanism by which HIV can become resistant to reverse transcriptase inhibitors?

A) Mutations in the protease gene
B) Mutations in the reverse transcriptase gene
C) Increased drug efflux
D) Enhanced drug metabolism

A

B) Mutations in the reverse transcriptase gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which drug is used as a pharmacokinetic booster to increase the serum concentrations of other protease inhibitors?

A) Abacavir
B) Cobicistat
C) Tenofovir
D) Lamivudine

A

B) Cobicistat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which adverse effect is commonly associated with the use of protease inhibitors boosting?

A) Nephrotoxicity
B) Neurotoxicity
C) Hyperlipidemia
D) Hepatotoxicity

A

C) Hyperlipidemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which NRTI is known for causing a hypersensitivity reaction in some patients, particularly those with the HLA-B*5701 polymorphism?

A) Tenofovir
B) Emtricitabine
C) Abacavir
D) Lamivudine

A

C) Abacavir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does HIV become resistant to non-nucleoside reverse transcriptase inhibitors (NNRTIs)?

A) By increasing drug efflux
B) By mutations in the NNRTI binding site on reverse transcriptase
C) By enhancing drug metabolism
D) By altering the viral envelope

A

B) By mutations in the NNRTI binding site on reverse transcriptase

17
Q

Which integrase inhibitor is known for having a long plasma half-life and does not require boosting?

A) Elvitegravir
B) Dolutegravir
C) Raltegravir
D) Bictegravir

A

B) Dolutegravir

18
Q

What is the primary mechanism by which protease inhibitors block HIV protease activity?

A) By binding to the active site and preventing substrate cleavage
B) By inhibiting viral entry into host cells
C) By blocking reverse transcription
D) By preventing integration of viral DNA into the host genome

A

A) By binding to the active site and preventing substrate cleavage

19
Q

Which NRTI is a deoxyguanosine analog?

A) Tenofovir
B) Emtricitabine
C) Lamivudine
D) Abacavir

A

D) Abacavir

20
Q

Which enzyme is responsible for the phosphorylation of NRTIs to their active triphosphate form?

A) Viral protease
B) Cellular kinases
C) Viral integrase
D) Cellular phosphatases

A

B) Cellular kinases

21
Q

What is the primary mechanism of action for integrase inhibitors?

A) Inhibition of viral entry
B) Inhibition of reverse transcription
C) Inhibition of protease activity
D) Inhibition of integration of viral DNA into the host genome

A

D) Inhibition of integration of viral DNA into the host genome

22
Q

Which integrase inhibitor is part of the combination drug Biktarvy?

A) Elvitegravir
B) Dolutegravir
C) Raltegravir
D) Bictegravir

A

D) Bictegravir

23
Q

Which protease inhibitor is a non-peptidomimetic? (slide 46)

A) Atazanavir
B) Darunavir
C) Tipranavir
D) Ritonavir

A

C) Tipranavir

24
Q

Which NRTI is known for its effectiveness in combination with emtricitabine?

A) Abacavir
B) Lamivudine
C) Stavudine
D) Tenofovir

A

D) Tenofovir

25
Q

Which NNRTI has a long half-life and is taken once daily?

A) Nevirapine
B) Efavirenz
C) Delavirdine
D) Etravirine

A

B) Efavirenz

26
Q

Which integrase inhibitor does not interact with CYP3A4 and has a higher barrier for resistance?

A) Elvitegravir
B) Raltegravir
C) Bictegravir
D) Dolutegravir

A

D) Dolutegravir

27
Q

Which NRTI is a deoxycytidine analog? (2 answers)

A) Tenofovir
B) Emtricitabine
C) Lamivudine
D) Abacavir

A

B) Emtricitabine
C) Lamivudine

28
Q

Which protease inhibitor is used in combination with cobicistat to boost its concentration?

A) Atazanavir
B) Darunavir
C) Tipranavir
D) Elvitegravir

A

D) Elvitegravir

29
Q

Which integrase inhibitor is part of the combination drug Genvoya?

A) Elvitegravir
B) Dolutegravir
C) Raltegravir
D) Bictegravir

A

A) Elvitegravir